Part,  Chapter, Paragraph

1   II,     5.  3.  7|     drug is also used in the adjuvant setting. For example, when
2   II,     5.  9.  4| inflammation in vivo, and on adjuvant potency in allergy animal
3   II,     5.  9.  4|    associated primarily with adjuvant activity for respiratory
4   II,     5.  9.  4|    significantly greater IgE adjuvant activity per unit mass than
5   II,     5.  9.  4|     the screening of allergy adjuvant activity since no correlation